They can directly lyse CD1d-positive malignancies, including hematologic and select solid tumors, and stress ligand-expressing tumor cells via Fas/FasL interactions, TRAIL-mediated apoptosis, or release of cytotoxic granules containing perforin and granzymes (23, 39, 40). The gene discussed is CD1D; the disease is neoplasm.